Protocol for the osteoporosis choice trial. A pilot randomized trial of a decision aid in primary care practice

Trials

Volumn 10, Issue , 2009, Pages

  Pencille, Laurie J ^a   Campbell, Megan E ^a   Van Houten, Holly K ^a   Shah, Nilay D ^a   Mullan, Rebecca J ^a   Swiglo, Brian A ^b   Breslin, Maggie ^a   Kesman, Rebecca L ^a   Tulledge Scheitel, Sidna M ^a   Jaeger, Thomas M ^a   Johnson, Ruth E ^a   Bartel, Gregory A ^a   Wermers, Robert A ^a   Melton III, L Joseph ^a   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

^b Allina Hospitals & Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; ARTICLE; BONE DENSITY; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FRACTURE; HEALTH SURVEY; HUMAN; INTERVIEW; MEDICAL PRACTICE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHARMACY; PILOT STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; VIDEORECORDING; DECISION MAKING; FOLLOW UP; METHODOLOGY; MIDDLE AGED; OSTEOPOROSIS; PRIMARY HEALTH CARE; RISK FACTOR;

DECISION MAKING; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PILOT PROJECTS; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 73149097669     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-113     Document Type: Article

References (42)

1. Bone Health and Osteoporosis: A Report of the Surgeon General. , http://www.surgeongeneral.gov/library/bonehealth/content.html
2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22:465-475. 10.1359/jbmr.061113, 17144789.
3. MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008, 148:197-213.
4. Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006, 81:1013-1022. 10.4065/81.8.1013, 16901023.
5. Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 2007, 18:271-277. 10.1007/s00198-006-0230-y, 17021945.
6. Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008, 19:811-818. 10.1007/s00198-007-0506-x, 17999022.
7. Penning-van Beest FJ, Erkens JA, Olson M, Herings RM. Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int 2008, 19:511-517. 10.1007/s00198-007-0466-1, 2267483, 17874028.
8. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007, 18:1023-1031. 10.1007/s00198-006-0322-8, 17308956.
9. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, Jonsson B, Pols H, Cramer JA. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 2007, 18:711-719. 10.1007/s00198-006-0294-8, 17245547.
10. Clinician's Guide to Prevention and Treatment of Osteoporosis. , http://www.nof.org/professionals/Clinicians_Guide.htm
11. Cuddihy MT, Amadio PC, Gabriel SE, Pankratz VS, Kurland RL, Melton LJ. A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 2004, 15:695-700. 10.1007/s00198-004-1597-2, 15007544.
12. Mauck KF, Cuddihy MT, Trousdale RT, Pond GR, Pankratz VS, Melton LJ. The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model. Osteoporos Int 2002, 13:560-564. 10.1007/s001980200073, 12111016.
13. Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B. Early discontinuation of treatment for osteoporosis. Am J Med 2003, 115:209-216. 10.1016/S0002-9343(03)00362-0, 12947959.
14. O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making 2007, 27:554-574. 10.1177/0272989X07307319, 17873255.
15. Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJ, Mullan RJ, Smith SA. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 2007, 167:1076-1082. 10.1001/archinte.167.10.1076, 17533211.
16. U.S. Preventive Services Task Force Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002, 137:526-528.
17. Lewiecki EM. Review of guidelines for bone mineral density testing and treatment of osteoporosis. Curr Osteoporos Rep 2005, 3:75-83. 10.1007/s11914-005-0014-x, 16131426.
18. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004, 164:1108-1112. 10.1001/archinte.164.10.1108, 15159268.
19. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033-1046. 10.1007/s00198-007-0343-y, 17323110.
20. Watts NB, Ettinger B, LeBoff MS. FRAX facts. J Bone Miner Res 2009, 24:975-979. 10.1359/jbmr.090402, 19364271.
21. Kanis JA, . World Health Organization Scientific Group Assessment of Osteoporosis at the Primary Health Care Level. Technical Report. 2007, World Health Organization Collaborating Centre for Metabolic Bone Diseases ed. Sheffield, UK: University of Sheffield.
22. Cranney A, O'Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, Ooi DS, Waldegger L, Goldstein R, Wells GA. Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns 2002, 47:245-255. 10.1016/S0738-3991(01)00218-X, 12088603.
23. Montori VM, Breslin M, Maleska M, Weymiller AJ. Creating a conversation: insights from the development of a decision aid. PLoS Med 2007, 4:e233. 10.1371/journal.pmed.0040233, 1939861,1939861, 17683195.
24. Breslin M, Mullan RJ, Montori VM. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ Couns 2008,
25. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008, CD001155.
26. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006, 144:753-761.
27. Koka S, Clarke BL, Amin S, Gertz M, Ruggiero SL. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient. Int J Prosthodont 2007, 20:115-122.
28. Mullan RJ, Montori VM, Shah ND, Christianson TJH, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA. The Diabetes Mellitus Medication Choice Decision Aid: A Randomized Trial. Arch Intern Med 2009, 169:1560-1568. 10.1001/archinternmed.2009.293, 19786674.
29. Jones LA, Weymiller AJ, Shah N, Bryant SC, Christianson TJ, Guyatt GH, Gafni A, Smith SA, Montori VM. Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. Med Decis Making 2009, 29:468-474. 10.1177/0272989X09333120, 19605885.
30. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002, 325:652-654. 10.1136/bmj.325.7365.652, 1124168, 12242181.
31. Thom DH, Ribisl KM, Stewart AL, Luke DA. Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care 1999, 37:510-517. 10.1097/00005650-199905000-00010, 10335753.
32. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995, 15:25-30. 10.1177/0272989X9501500105, 7898294.
33. Elwyn G, Hutchings H, Edwards A, Rapport F, Wensing M, Cheung WY, Grol R. The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Health Expect 2005, 8:34-42. 10.1111/j.1369-7625.2004.00311.x, 15713169.
34. Nannenga MR, Montori VM, Weymiller AJ, Smith SA, Christianson TJ, Bryant SC, Gafni A, Charles C, Mullan RJ, Jones LA, Bolona ER, Guyatt GH. A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial. Health Expect 2009, 12:38-44. 10.1111/j.1369-7625.2008.00521.x, 19250151.
35. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. Jama 2002, 288:2880-2883. 10.1001/jama.288.22.2880, 12472330.
36. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed?. JAMA 1993, 269:2779-2781. 10.1001/jama.269.21.2779, 8492406.
37. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008, 46:1125-1133. 10.1097/MLR.0b013e31817924d2, 18953222.
38. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006, 40:1280-1288. 10.1345/aph.1H018, 16868217.
39. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001, 165:1339-1341. 81628, 11760981.
40. Abadie R, Weymiller AJ, Tilburt J, Shah N, Charles C, Gafni A, Montori V. Clinician's use of the Statin Choice decision aid in patients with diabetes: a videographic study nested in a randomized trial. J Eval Clin Pract 2009, 15(3):492-7. 10.1111/j.1365-2753.2008.01048.x, 19366386.
41. Elwyn G, Legare F, Weijden T, Edwards A, May C. Arduous implementation: Does the Normalisation Process Model explain why it's so difficult to embed decision support technologies for patients in routine clinical practice. Implement Sci 2008, 3:57. 10.1186/1748-5908-3-57, 2631595, 19117509.
42. May CR, Mair F, Finch T, Macfarlane A, Dowrick C, Treweek S, Rapley T, Ballini L, Ong BN, Rogers A, Murray E, Elwyn G, Légaré F, Gunn J, Montori VM. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci 2009, 4:29. 10.1186/1748-5908-4-29, 2693517, 19460163.